Senomyx, Inc.
Senomyx Announces Initiation of Development Activities for New Sucrose Enhancer
Published in Obesity and Diabetes Week, August 11th, 2008
Senomyx, Inc. (NASDAQ:SNMX), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced that it has initiated development activities for a new sucrose enhancer, S6973. Sucrose (otherwise known as common table sugar) is widely used in many food and beverage products. Taste tests have demonstrated that S6973 enables the reduction of up to 50% of the sucrose present in product prototypes while maintaining the sweet taste of natural sugar.
"Senomyx believes that S6973 has the potential to be used to enhance the sweet taste of sucrose in numerous food and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- American Cancer Society
Prostate cancer patients undergoing hormone therapy may experience cognitive effects - American Society for Gastrointestinal Endoscopy
ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient - Tufts University, Health Sciences
Obesity predisposition traced to the brain's reward system - University of Utah
This old healthy house - Angiogenesis
Study data from J. Krupinski and co-authors update knowledge of angiogenesis - Cardiovascular Disease
Data on cardiovascular disease reported by researchers at Visva-Bharati University - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
